OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
CStone Pharmaceuticals OCF Yield % Related Terms
CStone Pharmaceuticals OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PH4 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, CStone Pharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CStone Pharmaceuticals OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CStone Pharmaceuticals's OCF Yield % distribution charts can be found below:
* The bar in red indicates where CStone Pharmaceuticals's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CStone Pharmaceuticals (FRA:PH4) has a OCF Yield % of -4.89 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on CStone Pharmaceuticals and its competitors. According to the industry distribution chart, CStone Pharmaceuticals ranks #589 out of 1419 companies in the Biotechnology industry, placing it in the top 41.5%.
Is CStone Pharmaceuticals' OCF Yield % too high?
CStone Pharmaceuticals' current OCF Yield % is -4.89. Based on the distribution chart, CStone Pharmaceuticals ranks #589 out of 1419 companies in the Biotechnology industry, which is above the industry midpoint. Overall, CStone Pharmaceuticals has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CStone Pharmaceuticals' OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CStone Pharmaceuticals ranks #589 out of 1419 companies for OCF Yield %. This puts CStone Pharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on CStone Pharmaceuticals and its competitors. CStone Pharmaceuticals's current OCF Yield % is -4.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CStone Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, CStone Pharmaceuticals (FRA:PH4) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.13, compared to a current price of €0.52 — trading 301.4% above its estimated fair value. The current OCF Yield % is -4.89. CStone Pharmaceuticals' overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For CStone Pharmaceuticals (FRA:PH4), the current OCF Yield % is -4.89 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CStone Pharmaceuticals (FRA:PH4) Overvalued in 2026?
Based on GuruFocus' analysis, CStone Pharmaceuticals stock appears to be overvalued.
The current stock price of €0.52 is trading 301.4% above its estimated GF Value™ of €0.13.
GuruFocus considers CStone Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for FRA:PH4:
OCF Yield %: -4.89
GF Value™: €0.13 vs. price of €0.52 (301.4% above fair value)
No single metric tells the full story. See the FRA:PH4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CStone Pharmaceuticals is engaged in developing and commercializing immuno-oncology and molecularly targeted drugs to address unmet medical needs in cancer treatment. The Group has been operating in one reportable segment, being the research and development of high-complex biopharmaceutical products, the sale of pharmaceutical products, and provide license of its IP or commercialisation licenses to customers.
56GF Score
Get the complete analysis for FRA:PH4
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PH4 has been successfully added to your 
